ClearPoint Neuro Inc
CLPT
Get informed when a big investor buys or sells
+ FollowMarket Cap$460.04M
Close$
$-10.94
170.9% downside
Current Fair Value
170.9% downsideOvervalued by 170.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $460.04 Million |
|---|---|
| Enterprise Value | $496.47 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.9 |
| Beta | 1.24 |
| Outstanding Shares | 29,858,476 |
Return
| Return on Equity | -320.77% |
|---|---|
| Return on Assets | -39.85% |
| Return on Invested Capital | -40.62% |
Valuation & Multiples
| P/E Ratio | -13 |
|---|---|
| PEG | -13.8 |
| Price to Sales | 15.42 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 11.74 |
| Enterprise Value to EBIT | -15.99 |
| Enterprise Value to Net Income | -15 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 6.11 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-0.27
Average shareholder expectationRevenue Estimate
$12.73 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.31
Average shareholder expectationRevenue Estimate
$12.27 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 55.08% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 15.47%▼ 28.51% |
|---|---|
| Total Invested | $81.36M▼ 31.23% |
| Investors Holding | 45▼ 80.00% |
ESG Score
No data